Benzinga | Sep 17, 2021 08:10AM EDT

Gain Therapeutics To Present At Oppenheimer Fall Healthcare Life Sciences, MedTech Summit Sept. 22 At 1:15 p.m. EDT

Gain Therapeutics, Inc. (NASDAQ:GANX) ("Gain", or the "Company"), a biotechnology company focused on identifying and optimizing allosteric binding sites never before targeted in neurodegenerative diseases and lysosomal storage disorders, today announced that Eric Richman, Chief Executive Officer of Gain Therapeutics, will present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit and invites investors to participate via webcast and in one-on-one meetings. Please see additional details below:

Oppenheimer Fall Healthcare Life Sciences & MedTech SummitDate: Wednesday, September 22ndTime: 1:15 to 1:55 p.m. ETPresenter: Eric Richman, Chief Executive OfficerWebcast: Registration Link ? Click Here * a replay will be available following the presentation for 90 days

Please contact your representative at Oppenheimer & Co. to schedule a virtual one-on-one meeting with Gain Therapeutics during the respective conference.

For more information about the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit, please refer to the conference website.